News Sentiment

TLX sentiment intelligence

Telix Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 11.14 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 58

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-6.1% over one week, +16.5% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing

Market Reaction

Price moving ahead of tone

69/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -6.1% Price reacting lower
Trend fit Trend active 16.5% over four weeks
Fair value -11.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 30
Neutral 32
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 58
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 7
Simply Wall Street 5
PR Newswire 3
The National Law Review 3
Kalkine 3
MT Newswires 2
Ad-hoc-news.de 2

Event Lens

What the news is about

Classified themes
Market update 43
Earnings 11
Regulatory and legal 5
Analyst action 2
Guidance 2
Deals and strategy 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 66
Simply Wall Street Direct company coverage

Telix Pharmaceuticals Stock And Two Australian Insider Led Growth Plays

This article examines Telix Pharmaceuticals, Lindian Resources, and GemLife Communities Group, highlighting them as growth plays led by insider ownership in Australia. Telix Pharmaceuticals is noted for its commercial radiopharmaceutical sales and oncology pipeline, Lindian Resou

Tone
Positive 66/100
Event
Market update
Published
27 Jun 2026 14:11
Source
Simply Wall Street
Ad-hoc-news.de Direct company coverage

Telix Pharmaceuticals clear FDA panel milestone, shares react in oncology sector context

Telix Pharmaceuticals (AU000000TLX2) is gaining investor attention following its progress in the FDA regulatory pathway for its radiopharmaceutical pipeline, particularly for prostate cancer imaging and treatment. The company operates in a competitive oncology sector alongside ma

Tone
Positive 70/100
Event
Regulatory and legal
Published
26 Jun 2026 15:11
Source
Ad-hoc-news.de